Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
Abstract Novel oral poliovirus vaccine type 2 (nOPV2) is being developed to reduce the rare occurrence of disease and outbreaks associated with the genetic instability of the Sabin vaccine strains. Children aged 1 to 5 years were enrolled in two related clinical studies to assess safety, immunogenic...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Nature Portfolio
2022-02-01
|
| Ráidu: | npj Vaccines |
| Liŋkkat: | https://doi.org/10.1038/s41541-022-00437-5 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|